Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma

Conditions:   Healthy;   Asthma
Interventions:   Drug: JNJ-43260295;   Drug: Placebo;   Other: Nasal Allergen Challenge
Sponsor:   Janssen Research & Development, LLC
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Condition:   Asthma
Interventions:   Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler;   Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler;   Drug: NEUMOTEX 400 (Budesonide 400 mcg);   Drug: Salbutamol 100 mcg pMDI
Sponsors:   GlaxoSmithKline;   Laboratorios Phoenix
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days